AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

XTL Biopharmaceuticals Ltd.

Foreign Filer Report Oct 31, 2019

7116_rns_2019-10-31_fbb93310-4051-41a4-9f79-a6bbf38ff1d1.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

Resignation of Mr. Oded Nagar, a non-executive and external director of the Company. false

��� �� �� ������������� ��"� 2 380
X T L BIOPHARMACEUTICALS LTD
Corporation no: 520039470 4313
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 31/10/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-093189 Time of broadcast: 17:09 17:02:32

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onResignation of Mr. Oded Nagar, a non-executive and external director of the Company.

f6k103119_xtlbiopharma_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 29/10/2019
Address: HaCharoshet st 5 , Ra'anana 43656   Israel , Tel: 09-9557080 , Fax: 09-9519708
E-mail address: [email protected]   Company site: www.xtlbio.com
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory: Kntor Ronen Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: abba hillel 12 , ramat gan 5250606 Telephone: 03-6133371 Facsimile: 03-6133372 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.